Skip to content

PR-Web

Press releases worldwide

  • Home
  • Contact
  • Datenschutzerklärung
  • Legal notice

Author: Firma elderbrook solutions

elderbrook solutions Ranks No. 1 in German Health Care & Life Sciences in Europe’s Long-Term Growth Champions 2027

Posted on 2. November 2026 by Firma elderbrook solutions Posted in General Tagged 039s, award, clinical, company, companys, covid, edition, elderbrook, energy, financial, project, research, revenue, solutions, with

elderbrook solutions GmbH has been named one of Europe’s Long-Term Growth Champions 2027, a ranking compiled by Statista in collaboration with the Financial Times. The contract research organization (CRO) took first place among all German companies in the Health Care […]

Read More

elderbrook solutions Receives BSFZ Certification: Development of Valido Recognized as Innovative Scientific Research

Posted on 21. October 202631. October 2026 by Firma elderbrook solutions Posted in General Tagged bsfz, ctms, edc, elderbrook, eTMF, inspection, may, new, prefilled, research, sas, smart, solutions, valido, with

elderbrook solutions GmbH today announced that the development of Valido, the Computerized System Validation (CSV) management tool within its Quontrol Suite, has been recognized as innovative research by the BSFZ, the German certification body for research allowance. The positive decision […]

Read More

Welcoming Dr. Jürgen Kübler as Our New CEO

Posted on 13. October 2026 by Firma elderbrook solutions Posted in General Tagged business, chapter, clarity, development, drug, elderbrook, energy, kbler, new, over, pharmaceutical, phase, solutions, strong, with

We are delighted to announce that Dr. Jürgen Kübler joined elderbrook solutions as our new CEO on 1 October 2026. With a strong background in pharmaceutical drug development with a quantitative scientific foundation, combined with almost a decade of experience […]

Read More

Copyright 2016. All rights reserved.


Back To Top
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.